Novartis’ Kisqali provides additional year of survival benefit, including for aggressive HR+/HER2- advanced breast cancer

Breast implant closes reconstruction gap for patients after mastectomy

Johnson & Johnson MedTech on May 13 announced the U.S. launch of MENTOR MemoryGel Enhance Breast Implants, filling a critical gap in comprehensive breast cancer care for women who have undergone a mastectomy.

May 16, 2025

Vol.51 No.19

Clinical Roundup

Incidence rates of some cancer types have risen in people under age 50, NCI study shows

Researchers at NCI have completed a comprehensive analysis of cancer statistics for different age groups in the United States and found that from 2010 through 2019, the incidence of 14 cancer types increased among people under age 50.

May 09, 2025

Vol.51 No.18

Clinical Roundup

Enhertu demonstrates superior efficacy over standard of care in HER2+ metastatic breast cancer

The DESTINY-Breast09 phase III trial of AstraZeneca and Daiichi Sankyo’s Enhertu is the first trial in more than a decade to demonstrate superior efficacy across a broad HER2-positive metastatic patient population versus current first-line standard of care.

April 25, 2025

Vol.51 No.16

In Brief

Hope Rugo named director of City of Hope’s Women’s Cancers Program

Hope S. Rugo has joined City of Hope to lead its Women’s Cancers Program throughout the organization and breast medical oncology division section.

April 18, 2025

Vol.51 No.15

Clinical Roundup

Researchers explore adapted Argentine tango dance therapy for cancer survivors at Ohio State

Adapted Argentine tango dance therapy is helping some breast cancer survivors regain natural balance and sensation after experiencing neuropathy, a common side effect of chemotherapy treatment. Expansion of a new clinical study will look further at how this musical movement intervention can “rewire” the brain to improve function after chemotherapy-related nerve changes.

April 18, 2025

Vol.51 No.15

In Brief

Less Radical, a podcast about Bernie Fisher, nominated for two Webby Awards

Less Radical, a documentary podcast that tells story of Bernie Fisher, a pioneering surgeon-scientist who redefined breast cancer treatment, was nominated for Best Podcast - Documentary and Best Indie Podcast – Limited Run in the 29th Annual Webby Awards.

April 04, 2025

Vol.51 No.13

Novartis’ Kisqali provides additional year of survival benefit, including for aggressive HR+/HER2- advanced breast cancer

YOU MAY BE INTERESTED IN

Breast implant closes reconstruction gap for patients after mastectomy

Incidence rates of some cancer types have risen in people under age 50, NCI study shows

Enhertu demonstrates superior efficacy over standard of care in HER2+ metastatic breast cancer

Hope Rugo named director of City of Hope’s Women’s Cancers Program

Researchers explore adapted Argentine tango dance therapy for cancer survivors at Ohio State

Less Radical, a podcast about Bernie Fisher, nominated for two Webby Awards

Renew today!

Subscriber content

Never miss an issue!

Login